Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Stelexis Therapeutics
780 Third Ave
New York, NY 10017
https://www.stelexis.com/

Stelexis is a cancer therapeutics company, utilizing its proprietary platform to selectively target pre-cancerous stem cells to discover and develop transformative therapies.

Key Contact
Name
Patrick Doyle
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
01/08/19 $43,000,000 Series A Deerfield Partners
undisclosed